Long Ideas - After immense pre-market trading, Dendreon (NASDAQ:DNDN) is down 22% to $4.85 on earnings and news that it will cut 600 jobs and close a New … Continue Reading
Read nowLong Ideas - Amarin Corp. (NASDAQ:AMRN) is trading sharply lower this morning on reports that members of management and the Board sold company stock and exercised options after … Continue Reading
Read nowLong Ideas - This morning, the little-known Omeros Corporation (NASDAQ:OMER) announced that it may have discovered the proteins that activate the alternative pathway of the complement system, an … Continue Reading
Read now- VRTX missed second quarter earnings by a wide margin on the top- and bottom lines. The company reported EPS of $0.46, nearly half of what … Continue Reading
Read now- Development-stage Lexicon Pharmaceuticals (NASDAQ:LXRX) served up a dish of dilution to its shareholders today, issuing 13.2MM shares of common stock to “designees of Symphony Icon … Continue Reading
Read nowLong Ideas - Belgian drug-maker ThromboGenics NV announced last Friday that it and ex-U.S. partner Novartis (NYSE:NVS) received a nod of approval from an FDA advisory panel investigating … Continue Reading
Read now- The EU released a round of new drug approvals today, including Novartis’ (NYSE:NVS) breast-cancer treatment Afinitor which was approved by the FDA two weeks ago. … Continue Reading
Read now